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Abstract
Paracoccidioides lutzii is a new agent of paracoccidioidomycosis (PCM) and has its epicenter localized to the Central-West
region of Brazil. Serological diagnosis of PCM caused by P. lutzii has not been established. This study aimed to develop new
antigenic preparations from P. lutzii and to apply them in serological techniques to improve the diagnosis of PCM due to P.
lutzii. Paracoccidioides lutzii exoantigens, cell free antigen (CFA), and a TCA-precipitated antigen were evaluated in
immunodiffusion (ID) tests using a total of 89 patient sera from the Central-West region of Brazil. Seventy-two sera were
defined as reactive for P. brasiliensis using traditional antigens (AgPbB339 and gp43). Non-reactive sera for traditional
antigens (n = 17) were tested with different P. lutzii preparations and P. lutzii CFA showed 100% reactivity. ELISA was found
to be a very useful test to titer anti-P. lutzii antibodies using P. lutzii-CFA preparations. Sera from patients with PCM due to P.
lutzii presented with higher antibody titers than PCM due to P. brasiliensis and heterologous sera. In western blot, sera from
patients with PCM due to P. lutzii were able to recognize antigenic molecules from the P. lutzii-CFA antigen, but sera from
patients with PCM due to P. brasiliensis could not recognize any P. lutzii molecules. Due to the facility of preparing P. lutzii
CFA antigens we recommend its use in immunodiffusion tests for the diagnosis of PCM due to P. lutzii. ELISA and western
blot can be used as complementary tests.
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Introduction
Paracoccidioidomycosis (PCM) is a mycotic disease caused by
species of the genus Paracoccidioides, a group of thermally dimorphic
fungi that grow in mycelial form at room temperature and as
budding yeasts when cultured at 37uC or in parasitism in host
tissues. PCM is limited to Latin American countries, and the most
important regions of endemicity are found in Brazil, Colombia,
and Venezuela [1]. PCM presents as two major clinical forms: the
acute or sub-acute form and the chronic form. In Brazil, PCM is
considered the eighth most common cause of death among
infectious and parasitic chronic diseases, with a mortality rate of
1.45 per million population [2]. However, PCM may be
considered a neglected disease because very few regions of this
country have official prevention programs.
The criteria for a definitive diagnosis of PCM are based on
demonstrating the presence of the fungus as multiple budding cells
in clinical materials. A culture is relatively difficult to obtain, and it
is a slow procedure. As an adjunct to clinical and histological
findings, serological tests can help establish a diagnosis. The
detection of antibodies in serum has been one of the main tools for
the diagnosis of PCM and may be useful for monitoring its
evolution and response to treatment. Among the different
serological techniques, the double immunodiffusion (ID) test is
the most commonly used and has a sensitivity of 80 to 95% [3].
Enzyme-linked immunosorbent assay (ELISA) has been em-
ployed in the serology of various mycotic diseases [4–8]. However,
ELISA has important limitations due to cross reactivity. In an
attempt to improve the specificity of ELISA for the diagnosis of
PCM, Albuquerque and Camargo [9] demonstrated that different
procedures are inefficient for eliminating all cross-reacting
antibodies and obtaining a specific diagnosis.
Exoantigens from cultures of P. brasiliensis were studied by
immunoblotting, and components were detected using serum from
patients with PCM. Anti-P. brasiliensis IgG reacted with four major
components of 70, 52, 43, and 20–21 kDa. The 43 kDa
glycoprotein (gp43) was the predominant IgG reactive antigen
and recognized by 100% of the patient sera, and the 70 kDa
glycoprotein was recognized by 96% of the tested sera. Both gp43
and gp70 can be considered to be markers for human PCM [10].
Until recently, PCM was assumed to be caused solely by P.
brasiliensis and transmitted to humans by inhalation of fungal
propagules from the mycelia phase occurring in nature. Recent
publications [11–12] support the idea of several cryptic Paracoc-
cidioides species being phylogenetically related. The real incidence
of each phylogenetic species and their implication on ecology and
clinical practice is difficult to establish because there is a lack of
information in the literature concerning the distribution of these
entities. The Phylogenetic Species Recognition (PSR) method
based on genealogical concordance (GCPSR) [13–14] has been
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used to detect limits in many pathogenic fungal species [15–17].
Using GCPSR methodology and several isolates of P. brasiliensis
from different regions of Latin America, Matute et al. [18]
concluded that P. brasiliensis is not a monotypic taxon, but a
complex of species: phylogenetic species 1 (S1), broadly distributed
through the Latin America [18–20], phylogenetic species 3 (PS3) is
restricted to clinical cases in Colombia [18–20], and a few isolates
in the clade phylogenetic species 2 (PS2) have been reported [18–
20] in Brazil and Venezuela. Phylogenetic analysis of 14 genes in
21 isolates revealed that isolate Pb01 cannot be grouped into any
of these species and constitutes a new clade [21]. Seventeen new
isolates belonging to this fourth cryptic species (Pb01-like) have
been identified, 16 of which originate in the Central-West region
of Brazil, and one from Ecuador [12]. Thus, Teixeira et al. [22]
proposed a new species, Paracoccidioides lutzii, which was formerly
known as ‘Pb01-like’ strains based on phylogenetic and compar-
ative genomics data, recombination analysis, and morphological
characteristics (Fig. 1). P. lutzii occurs mainly in the Central-West
region of Brazil, but it was also recently described in the northern
regions [23]. The Central-West region of Brazil is composed of the
states of Mato Grosso, Mato Grosso do Sul, and Goia´s, which can
be regarded as the areas with highest incidence of PCM caused by
P. lutzii. In the South and Southeast regions, P. brasiliensis is the
predominant species (Fig. 2).
With the introduction of dissimilar species, PCM serology has
been challenging for diagnosis. Several efforts highlight the
antigenic variability of this complex, which may have led to a
substantial number of false negative results. To date, no studies
describing the standardization of P. lutzii antigens for PCM
serology are available. In order to improve serological parameters
for the diagnosis of PCM caused by P. lutzii, the present study
presents a strategy for the immunodiagnosis of PCM caused by P.
lutzii by testing three types of antigenic preparations using ID,
ELISA, and Western blot.
Methods
Ethics statement
This study was approved by the Research Ethics Committee
with protocol number CAAE: 17177613.6.0000.5541 by Federal
University of Mato Grosso (UFMT) and protocol number 1796-10
by Universidade Federal de Sa˜o Paulo (UNIFESP). Protocol
number of Universidade Federal do Mato Grosso do Sul (UFMS):
354.989. All adult subjects provided informed written consent and
the study was approved by ethical committee under number
288.250/CEP/HUJM/UFMT.
Fungal strains
Fourteen isolates of P. lutzii were obtained from different regions
of Brazil (Table 1). Five isolates were obtained from the oral or
cutaneous lesions of patients from Ju´lio Muller University Hospital
(HUJM/UFMT) in Cuiaba´, MT, in the Central-West region of
Brazil. The clinical materials were collected by Dr. R. Hahn. Two
isolates were obtained in the North region (Para´ state) by Dr. S.H.
Marques-da-Silva [23]. Three isolates were isolated in Goia´s state
(Central-West region) and donated by Dr. C.M.A. Soares, and
four isolates were donated by Dr. E. Bagagli. P. lutzii was
confirmed by genotyping [12].
Genotyping of P. lutzii isolates
Fungal DNA was extracted from suspected colonies and
subjected to HSP70 gene amplification using the primers
HSPMMT1 (59-AAC CAA CCC CCT CTG TCT TG-39) and
PLMMT1 (59-GAA ATG GGT GGC AGT ATG GG-39) as
described by Teixeira et al. [12] in order to identify an exclusive
indel region of P. lutzii. P. lutzii Pb01 was used as a positive control
and P. brasiliensis B339 as a negative control.
Patient sera
For the ID study, 89 serum samples from PCM patients (75
males and 14 females, age range 23–78 years) were evaluated: 55
from Mato Grosso state (Cuiaba´ and region, Central-West region)
and 34 from Mato Grosso do Sul state (Campo Grande and
region, Central-West region). All patients presented with the
chronic form of the disease and exhibited clinical and laboratory
signs of the disease with pulmonary system involvement and
mucosal or mucocutaneous lesions. The diagnosis was endorsed by
the clinical experience of the physician responsible for the patient.
PCM was confirmed in most patients via direct examination of
secretions, such as sputum, oral mucosa lesion samples, and
biopsies. However, serological ID tests were not positive for all
patients when using the traditional exoantigen from P. brasiliensis
B339 (AgPbB339 standard antigen). As a gold standard, we used
three sera from PCM patients with positive cultures for P. lutzii
(positive control) determined by genotyping; sera and isolates were
obtained by R. Hahn). Heterologous sera from patients with
histoplasmosis (n = 15), sporotrichosis (n = 15), and aspergillosis
(n = 15) were also tested. Finally, 15 serum samples from healthy
individuals were also studied (negative control).
For ELISA, a batch of sera from Central-Western Brazil was
selected. Twenty-eight serum samples from patients with PCM
due to P. lutzii (previously confirmed by ID using P. lutzii antigen)
and 28 serum samples from patients with PCM due to P. brasiliensis
from Sa˜o Paulo, southeast region (previously confirmed by ID
using AgPbB339) were used in this assay. Among the sera from
patients with PCM caused by P. lutzii, three lacked treatment, 16
had 6 to 12 months of therapy, and 9 had 13 to 18 months of
treatment. As a gold standard or positive control, three sera from
PCM patients with positive cultures for P. lutzii were used.
Heterologous sera and negative controls were also studied.
For the Western blot assays, 12 serum samples from patients
with PCM due to P. brasiliensis and 12 serum samples from patients
with PCM due to P. lutzii (previously positive by ID and ELISA)
were used. Heterologous sera and negative control sera were also
studied.
Author Summary
Tropical diseases, such as paracoccidioidomycosis, are the
most common type of neglected diseases. From 1980 to
1995, 3,181 deaths from paracoccidioidomycosis occurred
in Brazil, representing the eighth most common cause of
death from predominantly chronic or recurrent types of
infectious and parasitic diseases, showing considerable
magnitude and low visibility. Paracoccidioidomycosis is
traditionally assumed to be caused solely by Paracoccid-
ioides brasiliensis, but a new species, Paracoccidioides lutzii,
was discovered in the Central-Western region of Brazil.
Thus, new antigenic preparations and tests for an accurate
differential diagnosis between these two species appear to
be needed. This study aimed to develop new antigenic
preparations from P. lutzii isolates to improve the diagnosis
of paracoccidioidomycosis. We used patient serum sam-
ples predominantly from the Central-Western region of
Brazil. Various antigenic preparations were tested, and a
cell free antigen derived from P. lutzii was an excellent
antigen for serological diagnosis and able to diagnose
100% of sera from patients with PCM due to P. lutzii.
Paracoccidioides lutzii Serology
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Antigenic preparations
P. lutzii exoantigen preparation: Culture medium and
growth conditions. Laboratories working with primary fungal
pathogens should handle live cultures in a biological safety cabinet.
The fungus was initially grown on Sabouraud medium (SAB;
Difco Laboratories) slant tubes for 3 days at 35uC. At that time,
growth consisting entirely of yeast cells was collected from at least
10 tubes, yielding an inoculum of approximately 26106 cells. Cell
aggregates were counted as single cells. Total counts were
expressed as the mean of three independent determinations.
These cells were inoculated into 500 ml of Fava Netto medium
[24] in 1800-ml Fernbach flasks. The flasks were incubated in a
rotator shaker (100 rpm) at 35uC for 7 days. After incubation, the
culture was killed with Thimerosal (0.2 g/l final concentration)
and returned to the shaker for 24 h, followed by plating on blood
agar slants. The slants were incubated for at least 72 h to ensure
that the cultures were non-viable. A presumptive test for viability
was microscopic observation of cells suspended in 0.4% trypan
blue dye. Dead cells take up the dye. Supernatant was collected
following paper filtration, concentrated under vacuum at 45uC,
and dialyzed against three changes of distilled water (3 liters each).
The molecular weight cut-off of the dialysis membrane was
10 kDa. After dialysis, if the final volume increased, the solution
was concentrated again. After this step, the antigen was tested by
ID. If positive reactions were obtained with the control sera, the
antigen was aliquoted and maintained at 220uC. If the reactions
were negative, the antigen was concentrated again and retested. In
general, a filtrate concentration of 20 to 30-fold was necessary.
The control serum consisted of serum from a PCM patient
infected with P. lutzii (gold standard). The protein concentration of
the preparations was determined using the Bradford method [25].
The presence of antigenic fractions was monitored by sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE)
[26] followed by silver staining. Finally, the antigen was tested by
the ID test.
Antigen precipitated with trichloroacetic acid (TCA) from
P. lutzii exoantigen. The same volume of exoantigen sample
(0.5 ml) was added to 20% TCA and incubated for 30 min under
slow stirring at 4uC [27]. The sample was centrifuged
(14,000 rpm) for 15 min at 4uC and the supernatant carefully
Figure 1. Electron microscopy of P. lutzii yeast phase showing multiple budding cells.
doi:10.1371/journal.pntd.0002986.g001
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removed. The precipitate consisted of 20 ml. Next, 200 ml of ice-
cold acetone was added to the precipitate and the mixture
centrifuged (14,000 rpm) for 5 min at 4uC. Finally, the superna-
tant was removed and the pellet allowed to dry before re-
suspension in 100 ml phosphate buffered saline (PBS) to constitute
the TCA-precipitate antigen.
Preparation of P. lutzii cell-free antigen (CFA). CFA
corresponds to molecules that are secreted by the fungus across the
cell wall, adhere to the surface of the fungus, and then released
during antigenic preparation. P. lutzii isolates were grown on SAB
(Difco Laboratories) at 35uC for 7 days. The fungal growth was
collected from five tubes by gently scraping the surface. The cell
mass was suspended in 1 ml of PBS, vortexed for 60 s, and
immediately centrifuged at 10,000 g in an Eppendorf tabletop
centrifuge for 60 s. The supernatant contained the CFA [28].
Protease inhibitor PMSF (20 mM final concentration) was added
to the CFA and finally lyophilized. Before use, each CFA
preparation was resuspended in saline. The protein concentration
varied between 1220 and 2000 mg/ml. All preparations were
tested by ID, ELISA, and Western blot with sera from PCM
patients. Control sera, such as positive sera, heterologous sera, and
negative sera were also included in the study. The protein contents
were determined using the Bradford method [25].
P. brasiliensis exoantigen and gp43 antigen. For the
traditional P. brasiliensis exoantigen preparations (AgPbB339), we
used P. brasiliensis B339 isolate as described previously [29].
Purified gp43 antigen was obtained by affinity chromatography of
the crude exoantigen of P. brasiliensis-B339 on Sepharose 4B-IgG
(Mab17c anti-gp43) (gift of Dr. R. Puccia). Gp43 was eluted from
the column using 0.1 M HCl-glycine buffer (pH 2.8) and
immediately neutralized with 2 M Tris (pH 9.0). The eluate was
freeze-dried, re-dissolved in sodium dodecyl sulphate (SDS) sample
buffer, and analyzed by SDS-PAGE.
Immunodiffusion assays
Three millimeters of melted 1% agarose (Sigma A-6877) in PBS
was poured onto a glass slide (75625 mm). The pattern for this
micro-ID test consisted of a central well surrounded by six wells,
Figure 2. Map of the Brazilian regions, highlighting the Central - West region where P. lutzii predominates and the South and
Southeast region where P. brasiliensis predominates.
doi:10.1371/journal.pntd.0002986.g002
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each 3 mm in diameter. The central well located 6 mm (edge-to-
edge) from the other wells was filled with the antigen solution. Each
slide contained two sets of wells. On each slide the two central wells
were filled with 10 ml of antigen. Slides were incubated overnight in
a moist chamber at room temperature (20–25uC), and then washed
for 1 h in 5% sodium citrate and for 24–48 h in saline. The slides
were dried, stained for 5 min with 0.15% Coomassie Brilliant blue
(Sigma) in ethanol: acetic acid: water (4:2:4; v:v), and destained in
the solvent mixture alone, when necessary. Precipitation bands were
recorded by visual observation [30].
Using different antigenic preparations for diagnosis
Suspected PCM sera were tested first by ID using the traditional
P. brasiliensis exoantigen (AgPbB339) and the purified gp43 antigen
from P. brasiliensis B339 in order to discriminate sera from patients
with PCM caused by P. brasiliensis. The non-reactive PCM sera,
which became the focus of this study, were tested with the three
different antigenic preparations. Scheme S1 outlines the final
strategy to distinguish sera from patients with PCM caused by P.
lutzii and P. brasiliensis.
ELISA
During pilot studies, CFA preparations from different P. lutzii
strains were tested and examined by checkerboard titration for
antibody detection and P. lutzii strain EPM 208 was chosen for this
study. The CFA was used in ELISA at 12.5 mg/ml to detect
circulating anti-P. lutzii antibodies. We selected 28 serum samples
from patients with PCM due to P. lutzii previously confirmed by
ID using CFA from P. lutzii EPM 208, 28 serum samples from
patients with PCM due to P. brasiliensis previously confirmed by ID
using AgPbB339 and gp43 as antigens, heterologous and negative
control sera. Serum samples from patients with PCM due to P.
lutzii were from Cuiaba-MT and Campo Grande-MS in the
Central-West region of Brazil. As a gold standard, we used three
sera from PCM patients with positive cultures for P. lutzii. All sera
from patients with PCM due to P. brasiliensis and heterologous sera
came from Hospital Sa˜o Paulo, Escola Paulista de Medicina (Sa˜o
Paulo, SP, Southeast region). All sera were divided into aliquots
and stored at 220uC.
Polystyrene flat-bottomed plates (Costar; 96-wells) were coated
with CFA (P. lutzii EPM 208) at 12.5 mg/ml diluted in 0.1 M
carbonate buffer (pH 9.6; 100 ml/well) and incubated for 2 h at
37uC and overnight at 4uC. The remaining binding sites were
blocked with PBS containing 0.1% Tween 20 (PBS-T) and 5%
non-fat dry milk (PBS-T-M) (200 ml/well) for 4 h at 37uC. After
washing three times with PBS-T, diluted serum (100 ml/well) (1:50
to 1:204,800 in PBS-T) was added for 1 h at 37uC. After washing
three times with PBS-T, 100 ml of goat anti-human IgG-
peroxidase (Sigma) (1:1000 in PBS-T) was added in each well
and incubated for 1 h at 37uC. After three washes with PBS-T,
100 ml of substrate solution (5 mg of o-phenylenediamine in 25 ml
of 0.1 M citrate-phosphate buffer pH 5.0 plus 10 ml of 30% H202)
was added to each well, and the reaction was interrupted after
8 min in the dark by the addition of 50 ml of 4 N H2SO4. The
optical density was read at 492 nm with a Tecan Sunrise 96 well
Microplate Reader (Tecan, Gro¨dlg, Austria).
The same sera were tested by ELISA using the classical
exoantigen from P. brasiliensis B339 (AgPbB339) at 10 mg/ml as
determined by checkerboard titration.
SDS-PAGE and western blotting
For the immunoblot study we used CFA from P. lutzii strain
EPM 208 (10 mg/lane) and CFA from P. brasiliensis B339 (10 mg/
lane). Sera that reacted with these two different antigens were
compared. The gels and reagents for SDS-PAGE were prepared
as described previously [31]; a 10% resolving gel and 3%
acrylamide stacking gel were used. After electrophoresis, the gels
were stained with Coomassie Blue solution (0.1% Coomassie Blue,
45% methanol, and 10% glacial acetic acid), and excess stain was
removed with destaining solution (10% glacial acetic acid and 10%
methanol). We selected 12 sera from patients with PCM due to P.
lutzii previously confirmed by ID using CFA from P. lutzii strain
EPM 208 and 12 sera from patients with PCM due to P. brasiliensis
previously confirmed by ID using AgPbB339 and gp43 as
antigens. For Western blot, the samples were transferred to
nitrocellulose membranes (Milipore) according to Towbin et al.
[26]. Gel contents were electrotransferred to nitrocellulose
membranes at 400 mA for 1 h in a Trans-Blot cell (Bio-Rad)
Table 1. Paracoccidioides lutzii isolates used in the study.
EPM* code Original Code Species Origen Donated by
EPM 147 Pb01 P. lutzii Goia´s Dra. C. M. A. Soares
EPM 148 8941 P. lutzii Goia´s Dra. C. M. A. Soares
EPM 196 11MFC P. lutzii Mato Grosso Dra. R. Hahn
EPM 201 1578 P. lutzii Goia´s Dra. C. M. A. Soares
EPM 205 RO-SC 102810 P. lutzii Rondoˆnia Dr. E. Bagagli
EPM 206 Pb66 P. lutzii Goia´s Dr. E. Bagagli
EPM 208 EP01 P. lutzii Goia´s Dr. E. Bagagli
EPM 209 Pb 8334 P. lutzii Goia´s Dr. E. Bagagli
EPM 212 IEC-2005 P. lutzii Para´ Dra. S. H. M. da Silva
EPM 213 IEC-1744 P. lutzii Para´ Dra. S. H. M. da Silva
EPM 226 2912 P. lutzii Mato Grosso Dra. R. Hahn
EPM 223 RH9840 P. lutzii Mato Grosso Dra. R. Hahn
EPM 227 3159 P. lutzii Mato Grosso Dra. R. Hahn
EPM 228 2875 P. lutzii Mato Grosso Dra. R. Hahn
*EPM= Escola Paulista de Medicina, Universidade Federal de Sa˜o Paulo, Sa˜o Paulo, Brazil.
doi:10.1371/journal.pntd.0002986.t001
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containing transfer buffer (25 mM Tris-HCl, 192 mM glycine,
and 20% methanol [vol/vol]; pH 8.3). Free binding sites in the
membranes were blocked by incubation for 2 h in 5% (wt/vol)
non-fat dry milk in PBS-T (pH 7.5). Membranes were sliced
vertically and the strips were incubated for 1 h at room
temperature with diluted serum (1:500 in PBS-T containing 5%
non-fat milk; PBS-T-M). The strips were washed in PBS-T-M
four times for 10 min each. The membranes were incubated with
peroxidase-conjugated goat anti-human IgG (Sigma) at 1:1,000
dilution for 1 h and then washed as above. The reactive antigenic
molecules were developed by chemiluminescence mix reagents
(Millipore, WBKLS0500) onto the membrane which is reactive to
the conjugated secondary antibody peroxidase and luminol. To
image the blot, we placed the transferred membrane in the
transluminator UVITEC imager (Uvitec Cambridge, United
Kingdom). The software settings in the Allience 4.7 software were
set up to take several images from different time exposures,
starting at 2 seconds with a total of ten images between
2 seconds. Then we selected the best time exposure from those
10 pictures taken.
Statistical analysis
Performance measured analyzed for each test were: sensitivity,
specificity, positive predictive value (PPV) and negative predictive
value (PNV). The receiver operating characteristics (ROC) curve
was drawn to determine the sensitivity and specificity for each
antigen preparation (CFA, EXO and TCA) in ID test. The areas
under ROC curves (AUC) were calculated to evaluate the
diagnostic values of each antigen preparation. We assumed a test
without diagnostic power when the ROC curve was linear with
AUC of 0.5 (the ROC curve will coincide with the diagonal). A
powerful test would give an AUC around 1.0, demonstrating the
absence of both false positives and false negatives (the ROC curve
will reach the upper left corner of the plot). To measure the degree
of concordance of the results of the different assays, the kappa
statistic and its 95% confidence interval (95% CI) were calculated.
Kappa values were interpreted as follows: 0.00–0.20, poor
agreement; 0.21–0.40, fair agreement; 0.41–0.60, moderate
agreement; 0.61–0.80, good agreement; 0.81–1.00, very good
agreement [32]. A p value of ,0.05 was considered to indicate
statistical significance. All statistical calculations were performed
with the MedCalc Statistical Software version 13.2.0 (MedCalc
Software bvba, Ostend, Belgium; http://www.medcalc.org; 2014).
Results
Suspected Paracoccidioides spp. isolates were subjected to HSP70
gene amplification. All clinical isolates had positive amplification
and were identified as P. lutzii (Figure S1). During pilot studies,
various P. lutzii CFA preparations were tested by ID; three were
not reactive (Fig. 3A). P. lutzii strain EPM 208 was chosen for the
CFA preparation based on the good and rapid growth of this
strain, as well as the good bands observed on the slide. Fig. 3B
shows that antigens (CFA) from P. brasiliensis Pb18 and B339 do
not react with P. lutzii serum.
In ID tests, 59 (66.2%) of 89 patient sera were reactive to the
classical antigen AgPbB339, indicating that these sera were from
patients with PCM due to P. brasiliensis. The 30 sera that were not
reactive were re-tested with P. brasiliensis-gp43 purified antigen,
and 13 (43.3%) were reactive, indicating that they were also from
patients with PCM due to P. brasiliensis. Some of these serum
samples were positive only for gp43 when tested with different
protein concentrations of gp43 (Figure S2). The 17 non-reactive
sera were re-tested with three antigenic preparations from P. lutzii
strain EPM 208. Ten (58.8%) of the sera were reactive to the
exoantigen preparation, but a weak precipitated band was
observed (Fig. 3C). Only 3 (17.6%) of the sera were reactive to
TCA-precipitated antigen, resulting in bands of low intensity
(Fig. 3C). Figure 3D shows that antigens from P. brasiliensis B339
(Ag Exo, TCA or CFA) do not reacted with serum from PCM
patient due to P. lutzii. In contrast, all 17 (100%) sera were reactive
to the CFA, resulting in sharp bands (1, 2 or 3 bands) (Fig. 3E).
Figure 3F shows that antigen from Exo B339 or CFA B339 do not
reacted with serum from PCM patient due to P. lutzii and that
antigen from Exo-PI or CFA-PI do not reacted with serum from
PCM patient due to P. brasiliensis. Among those 17 reactive sera
with CFA P. lutzii, 2 (11.7%) of them also reacted weakly with P.
brasiliensis CFA antigen, indicating cross-reactivity between these
two species. The most sensitive antigenic preparation was CFA-Pl,
with a sensitivity 100% (IC 80.5–100) and specificity 100% (IC
94–100), followed by Exo-Pl with a sensitivity 58.82% (32.9–81.6)
and specificity 100% (IC 94–100) and TCA-Pl with a sensitivity
17.65% (3.8–43.4) and specificity 100% (IC 94–100). Positive and
negative predictive values (PPV, NPV) in ID assay were higher for
CFA-Pl (PPV=100, IC 79.4–100; NPV=100, IC 94–100),
followed by Exo-Pl (PPV=100, IC 66.3–100, NPV=89.55, IC
79.6–95.6) and TCA-Pl (PPV=100, IC 15.8–100; NPV=22.07,
IC 70.3–89.2). Heterologous sera and serum samples from healthy
individuals (negative control) did not react with the tested antigens.
We used the area under the ROC curve (AUC) to evaluate the
discriminatory values of the antigens (comparing subjects with
PCM due to P. lutzii and those without the disease). Our results
showed that the CFA-Pl antigen afforded better AUC values
(AUC=1.0, IC 0.95–1.0, p,0.0001) than those for the Exo-Pl
(AUC=0.7460.06, IC 0.68–0.87, p,0.0001) and TCA-Pl
(AUC=0.5860.04, IC 0.47–0.69, p=0.0641) (Fig. 4). Judging
from the deviating performance of different antigen preparations
in ID assays we discarded the Exo-Pl and TCA-Pl antigens in
subsequent experiments.
For ELISA, the CFA from P. lutzii strain EPM 208 showed
excellent reactivity for antibody detection using PCM sera (P. lutzii
and P. brasiliensis) and heterologous sera (histoplasmosis, aspergil-
losis and sporotrichosis) and normal human sera as negative
control. Figure 5A shows the individual serum titers of patients
with PCM due to P. lutzii (sera # 1 to 28) and P. brasiliensis (sera #
29 to 58). Among P. lutzii sera, # 1, 2, and 6 represent the gold
standard sera and sera from patients lacking treatment; 3, 4, 5, and
7 to 19 represent sera from patients who received 6 to 12 months
of therapy; and 20 to 28 represent sera from patients with more
than 12 months of therapy. Figure 5B shows these same groups of
sera reacting with exoantigen from P. brasiliensis B339 (traditional
antigen: AgPbB339). Figure 5C shows the median curve of 28
PCM sera (P. lutzii) compared to the median curve of 28 PCM sera
(P. brasiliensis) and heterologous sera (histoplasmosis, aspergillosis
and sporotrichosis), besides the NHS used as negative control.
Figure 5D shows the results of the same set of sera but expressed
by the titers of each serum. The heterologous sera and NHS
always showed much lower titers in relation to the PCM sera. On
an overall, we observed that the cross-reactivity with heterologous
sera and NHS does not interfere with the interpretation of results
with homologous sera and P. lutzii CFA antigen. Most of the sera
from patients with PCM due to P. lutzii presented with titers from
1:12,800 to 1:204,800 (median = 51,200), whereas sera from
patients with PCM due to P. brasiliensis presented with maximum
titers of 1:6.400 (median= 1: 1,600), indicating a great difference
between the sera. Among the heterologous sera the maximum of
cross-reactivity was 1:1,600 for aspergillosis (median = 1:200),
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1:800 for histoplasmosis (median = 1:200), 1:400 for sporotrichosis
(median = 1:200). NHS reacted until 1:400 (median= 1:200).
Western blot allowed us to distinguish PCM due to P. lutzii and
due to P. brasiliensis, as only sera from patients with PCM due to P.
lutzii are able to recognize antigenic molecules from P. lutzii-CFA
(Fig. 6A). Sera from patients with PCM due to P. brasiliensis did not
recognize any P. lutzii CFA antigens (Fig. 6B). In addition, we used
Kappa test to assess the agreement between different serological
assays (ID, ELISA and Western blot) based on CFA-Pl antigen.
Kappa test (k=1) revealed a perfect agreement between all
pairwise comparisons for different assays.
In order to verify cross-reactions between both Paracoccidioides
species, sera from patients with PCM due to P. brasiliensis and due
to P. lutzii were tested against CFA from B339 (Fig. 6C and
6D).The results showed that sera from PCM due to P. brasiliensis
recognized only gp43 molecule; sera from PCM patients due to P.
lutzii recognized various molecules. Considering the main bands
evidenced, the reactivity were almost similar to that obtained with
P. lutzii sera and CFA-Pl.
Discussion
The World Health Organization (WHO) estimates that more
than 1 billion people, one-sixth of the world’s population, suffer
from one or more neglected diseases. The diseases are most heavily
concentrated in low-income nations in Africa and Latin America,
and the most common types of neglected diseases are tropical
diseases. Many neglected tropical diseases are caused by parasites,
which are spread by insects or contact with contaminated water or
soil (http://www.who.int/neglected_diseases/diseases/en/). In this
scenario, PCM can be considered a neglected disease. Coutinho et
al. [2] analyzed 3,181 deaths from PCM in Brazil based on 16 years
of sequential data (from 1980 to 1995). During this period, PCM
showed considerable magnitude and low visibility, representing the
eighth most common cause of death from predominantly chronic or
recurrent types of infectious and parasitic diseases. The study
showed that the mortality rate justifies classifying this disease as an
important health problem in Brazil. However, no government
programs exist for this mycosis, with rare punctual exceptions.
Figure 3. A) Immunodiffusion tests with different CFAs from 12 strains of Paracoccidioides lutzii. 1 = EPM 147; 2 = EPM 148; 3 = EPM 196;
4 = EPM 201; 5 = EPM 205; 6 = EPM 206; 7 = EPM 208; 8 = EPM 212; 9 = EPM 213; 10 = EPM 223; 11 = EPM 209; 12 = EPM 226. In the center well, S*= P.
lutzii serum (gold standard). P. lutzii strains EPM 227 and EPM 228 were positive (not shown). B) Immunodiffusion test showing that S*= P. lutzii gold
standard serum do not react with CFA from P. brasiliensis Pb18 and B339. C) Immunodiffusion test using Ag Exo (crude exoantigen of P. lutzii) and Ag
TCA (crude exoantigen of P. lutzii precipitated with trichloroacetic acid) versus P. lutzii serum (S*= P. lutzii gold standard serum and S= suspected P.
lutzii serum). Observe the weak band in both cases. D) immunodiffusion test showing that S* (P. lutzii gold standard serum) do not react with Ag Exo,
Ag TCA and CFA from P. brasiliensis B339 antigen. E) Immunodiffusion test of 12 sera from patients with PCM due to P. lutzii using P. lutzii CFA. In the
center well is the CFA antigen (Ag), and different PCM sera are in the peripheral wells (1 to 12). F) Immunodiffusion test showing that S* (P. lutzii gold
standard serum) do not react with Exo or CFA of P. brasiliensis B339; and SPb (serum of PCM patient due to P. brasiliensis) do not react with Exo or CFA
of P. lutzii.
doi:10.1371/journal.pntd.0002986.g003
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For a century PCM was thought to be caused solely by P.
brasiliensis, but recent studies [11,12,18–21,33] have shown that
other species of Paracoccidioides can also cause PCM. These findings
reveal that problems in the serological diagnosis of PCM were due
to an incorrect use of antigens from the genus, as only antigens of
P. brasiliensis (PS3) have been used for this purpose. With the
discovery of P. lutzii, it became clear that new antigens from these
new species would be needed to obtain more accurate diagnoses.
Recently, a fatal case of PCM due to P. lutzii fungemia was
reported [34] and other two cases were reported in the North
region of Brazil [23].
Until recently, the serological diagnosis of PCM by ID could be
accomplished using only the standard exoantigen from B339,
which has a high concentration of gp43 antigen, the immuno-
dominant and specific molecule in ID tests. Early suspicions that
this serology was not entirely certain were raised by our group
[35] when we observed that an exoantigen produced from an
isolate (Pb550B) from the Central-West region of Brazil was
capable of reacting with a larger number of PCM sera from that
region than the standard antigen from an isolate from Sa˜o Paulo
in the Southeast region (AgPbB339). Nevertheless, when tested
with PCM sera from Sa˜o Paulo, the antigen from the Central-
West region of Brazil did not produce satisfactory results. Also,
when we used the standard antigen AgPbB339, it reacted very
well with sera from Sa˜o Paulo, but very poorly with sera from the
Central-West region. Analyses of antigens obtained from the
B339 and 550B isolates showed that the former produced high
levels of gp43, which was undetected in the 550B filtrate. This
variation in gp43 expression likely influences the low reactivity
observed in ID tests using sera from patients from the Central-
West region of Brazil. At that time, nothing was known about P.
lutzii; therefore, we suggested using regional strains to aid in the
diagnosis of PCM for the Central-West region. Importantly, B339
belongs to the S3 species, whereas isolate 550B is from the
Central-West region of Brazil, where P. lutzii is more frequently
found.
Figure 4. Receiver operating characteristics (ROC) curve for the CFA, EXO and TCA antigens derived from Paracoccidioides lutzii
EPM208 isolate. The ROC is plotted between the true-positive rate (sensitivity) on the y-axis, and the false-positive rate (100-specificity) on the x-
axis. The area under the curve (AUC) represents the accuracy of the ID test which was 1.0, IC 0.95–1.0, p,0.0001 for the CFA, 0.7460.06, IC 0.68–0.87,
p,0.0001 for the EXO and 0.5860.04, IC 0.47–0.69, p = 0.0641 for the TCA antigens. The higher AUC above 0.5, the better the test.
doi:10.1371/journal.pntd.0002986.g004
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The main fact that spurred this study was the observation that
sera from patients with PCM (previously proven by direct
examination of secretions or histopathological analysis) were
negative by conventional serology using the standard AgPbB339
antigen in ID tests. In order to elucidate the problem with
serological diagnosis, we developed a strategy. First, all sera from
patients suspected of PCM should be tested against the traditional
exoantigen of P. brasiliensis (AgPbB339) and purified gp43 molecule
derived from the same standard strain. The reactive sera were then
considered to be PCM due to P. brasiliensis. The non-reactive sera
were then tested against CFA from P. lutzii EPM 208.
Applying this strategy, we were able to diagnosis 72 patients
with PCM due to P. brasiliensis. The remaining non-reactive
patients (n = 17) were diagnosed mostly by ID using CFA from P.
lutzii and also by ELISA and Western blot. This type of antigen
(CFA) is very easy to prepare and is very useful in the diagnosis of
PCM due to P. lutzii, exhibiting clearly visible precipitation bands.
Among these 17 sera, 2 of them also reacted with the traditional
exoantigen B339, but with a weak reactivity, indicating cross
reaction between these two species of Paracoccidioides. However, the
exoantigen preparation (from P. lutzii) also managed to obtain
positive reactions, but the precipitation line was very weak, making
it difficult to read the slides. In addition, the antigenic preparations
obtained by TCA precipitation were useful, but the bands were
quite weak. In both later antigens, the sensitivity of the reactions
was lower than that obtained with the CFA preparation.
Thus, the CFA preparation obtained from P. lutzii EPM 208
was the better antigen for use in ID tests to diagnosis PCM due to
P. lutzii from the Central-West region of Brazil. Other P. lutzii
strains were tested with similar results; however, among 14 CFA
preparations, three were unable to precipitate antibodies in sera
from P. lutzii-PCM patients, indicating that antigenic differences
exist among these strains. Therefore, more studies are necessary to
elucidate the antigenic variability among P. lutzii strains. Another
curiosity we observed when we tested CFA preparations from P.
lutzii in the ID tests was that better results were obtained when the
protein concentrations of the antigen were greater than 1200 mg/
ml. Protein concentrations less than 1200 mg/ml resulted in very
weak bands, hindering the visualization of precipitation reactions.
Machado et al. [36] described CFA as being inefficient for the
diagnosis of PCM due to P. lutzii.
In ELISA, sera from patients with PCM due to P. lutzii
presented with higher antibody titers than those obtained for the
sera from patients with PCM due to P. brasiliensis which can
perfectly differentiate between patient sera from P. brasiliensis and
P. lutzii. Heterologous sera, such as histoplasmosis, aspergillosis
Figure 5. A) Individual serum ELISA titers (1/T) of 28 sera from patients with PCM due to P. lutzii (blue) compared to individual
serum ELISA titers (1/T) of 28 sera from patients with PCM due to P. brasiliensis (red) reacting with Ag CFA-Pl EPM 208 (12.5 mg/ml).
The P. lutzii sera presented ID + for P. lutzii CFA antigen and ID 2 for P. brasiliensis exoantigen (AgPbB339). The group of P. brasiliensis sera presented
ID + for AgPbB339 antigen and ID2 for P. lutzii CFA antigen. (*) represents P. lutzii gold standard serum and (**) represents sera that had a very weak
cross reaction with P. brasiliensis exoantigen. B) Individual serum ELISA titers (1/T) of 28 sera from patients with PCM due to P. lutzii (blue) compared
to individual serum ELISA titers (1/T) of 28 sera from patients with PCM due to P. brasiliensis (red) reacting with Ag Exo Pb B339 (10 mg/ml). The P.
lutzii sera presented ID + for P. lutzii CFA antigen and ID 2 for P. brasiliensis exoantigen (AgPbB339). The group of P. brasiliensis sera presented ID +
for AgPbB339 antigen and ID 2 for P. lutzii CFA antigen. (*) represents P. lutzii gold standard serum and (**) represents sera that had a very weak
cross reaction with P. brasiliensis exoantigen. The same group of sera was used in A and B. C) ELISA median curves from sera from patients with PCM
due to P. lutzii, PCM due to P. brasiliensis, and heterologous sera such as histoplasmosis, aspergillosis, sporotrichosis, and normal human serum.
Antigen used was P. lutzii CFA (Ag CFA-Pl EPM 208 at 12.5 mg/ml). D) ELISA individual serum titers (1/T) of patients with PCM due to P. lutzii, P.
brasiliensis, and heterologous sera such as Histoplasmosis, Aspergillosis, Sporotrichosis and normal human sera. By the end titer we could distinguish
sera of PCM patients due to P. lutzii from sera of PCM due to P. brasiliensis and other mycotic diseases. Antigen used was P. lutzii CFA (Ag CFA-Pl EPM
208 at 12.5 mg/ml). Bars indicate the median.
doi:10.1371/journal.pntd.0002986.g005
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and sporotrichosis and normal human sera exhibited very low
cross-reactivity and did not interfere with interpretations of the
main system. It was expected that the sera from PCM patients due
to P. brasiliensis reacted more intensively with P. lutzii antigens
because these two species belong to the same genus. Certainly, the
antigenic components present in P. lutzii are constituted by specific
antigens of this species plus common antigens shared with P.
brasiliensis. Probably, antibodies elicited during infection by P.
brasiliensis are only generated against antigens from this species
whereas antibodies elicited during infection by P. lutzii are
generated by specific antibodies against antigens in this species
and also against antigens shared with P. brasiliensis. It was also
expected that sera from patients with PCM due to P. brasiliensis
reacted more intensively than heterologous sera (histoplasmosis,
aspergillosis and sporotrichosis), and not almost in the same level.
Perhaps, these results may be explained by the presence of
common antigens among P. brasiliensis and heterologous fungi,
which are reacting in this ELISA system.
In relation to the strategy used for immunoblotting in the
present study, we found that sera from patients with PCM due to
P. brasiliensis do not recognize any antigen from P. lutzii CFA. In
contrast, sera from patients with PCM due to P. lutzii were able to
recognize antigens from both antigenic preparations (CFA from P.
lutzii or P. brasiliensis). Therefore, P. lutzii is antigenically more
complex. These findings suggest that P. lutzii has its own species-
specific antigens and antigens common with P. brasiliensis. Thus,
we can distinguish between sera from patients with PCM due to P.
brasiliensis and those with PCM due to P. lutzii. However, the
specific P. lutzii antigen still needs to be identified. The reactivity of
PCM sera due to P. brasiliensis predominantly to gp43 of its
homologous antigen may be explained by the fact of the great
immunogenicity of this molecule, so that, the immune response to
other minor molecules is not evidenced.
Based on our results, we estimate that the incidence of PCM due
to P. lutzii is much greater than we imagine, even though the
Central-West region of Brazil where the disease is prevalent has
not invested in acquiring new tools for a specific diagnosis of this
entity. In general, laboratories for the diagnosis of infectious
diseases are small, have few resources, and perform a limited
number of tests per day. Our strategy meets all of the requirements
for use in laboratories for the diagnosis of PCM due to P. lutzii, as
well as seroepidemiological studies. In addition, the test does not
require special skills and can be used for a small number of
samples. Although the cost of ELISA and Western blot is higher
than that of ID, they are economical if the costs associated with
laboratory personnel, quality control, and reagent storage are
taken into account.
Surely P. lutzii is not confined to the Central-West region of the
country; we have described two cases in the northern region (Para´
State) [23], and we have strains of P. lutzii isolated in the Rondoˆnia
State (North region) and Parana´ (South region) in our fungal
collection. With our proposed strategy for the diagnosis of PCM
caused by P. lutzii, many new cases may arise throughout Brazil
and other South American countries. Studies are underway in our
laboratories to identify the species-specific antigen for P. lutzii in
order to use it for simple and specific diagnosis of this mycosis.
Supporting Information
Figure S1 PCR for molecular identification of P. lutzii
strains. The primers amplify HSP70 only in P. lutzii. M=mo-
lecular weight standard in bp. 1=EPM 147; 2 =EPM 148;
3 =EPM 193; 4=EPM 201; 5=EPM 205; 6=EPM 206;
7 =EPM 208; 8 =EPM 209; 9=EPM 212; 10=EPM 213;
11=EPM 226; 12=EPM 223; 13=EPM 227; 14=EPM 228;
15=B339 (P. brasiliensis). C - = negative control reaction. Note:
EPM 147 is Pb01 (P. lutzii, classical strain) and the positive control.
(TIF)
Figure S2 Immunodiffusion tests showing the reactivity
of three sera from patients with PCM due to P.
brasiliensis with different concentrations of gp43. A)
Serum S1 reacted with gp43 at 500 ng. B) Serum S2 reacted with
gp43 at 250 ng. C) Serum S3 reacted with gp43 at 31 ng. Most of
the sera reacted very well at 4, 2, or 1 mg of gp43 per well (data not
shown).
(TIF)
Scheme S1 Immunodiffusion slide scheme. Left, disposi-
tion of the different antigenic preparations for the diagnosis of
PCM due to P. brasiliensis. Right, disposition of the antigens for
diagnosis of PCM due to P. lutzii. AgPbB339= classical antigen for
diagnosis of PCM by P. brasiliensis; gp43= purified antigen from
exoantigen AgPbB339, specific fraction for PCM by P. brasiliensis;
CFA-PI (EPM 208) = cell free antigen from P. lutzii strain EPM
208.
(TIF)
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